Infection Current Awareness Update 11/04/2022
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Infection Current Awareness Update – 11/04/2022 Welcome to the weekly Infection Current Awareness Update (ICAU), produced by UKHSA Knowledge and Library Services. The purpose of this update is to provide you with the latest, best evidence about infection, to help you make informed decisions. Please note: UKHSA KLS has set up a separate COVID-19 Daily Alert of latest research. If you would like to receive this, please email libraries@phe.gov.uk. In addition to this, a page of resources about the coronavirus is available here. If you have any queries, please contact us at libraries@phe.gov.uk, and if you would like to request a literature search, please use the Knowledge and Library Services Enquiries Portal. Please note that not all the articles and resources referred to in this alert are freely available. Some articles may require an Athens username and password. For further information on Athens accounts please visit here. If you are not eligible to access our library services, then you may want to approach your local NHS library service. We do not accept responsibility for the availability or reliability of the items of content included in this alert and their inclusion is not an endorsement of any views that may be expressed. Infection-related guidance • British Medical Association - 1 • British Society for Antimicrobial Chemotherapy - 1 • European Centre for Disease Prevention and Control - 1 Infection-related journals • American Journal of Infection Control - 1 • Clinical Infectious Diseases - Advance Access - 11 • Clinical Infectious Diseases - Current Issue - 35 • Clinical Microbiology and Infection - 5 • Emerging Infectious Diseases Journal - ahead of print - 13 • European Journal of Clinical Microbiology & Infectious Diseases - 3 • Eurosurveillance latest updates - 5 • Hepatology - 1 • Infection - 5 • Infection Control & Hospital Epidemiology - FirstView Article - 7 • International Journal of Infectious Diseases - 28 • Journal of Clinical Microbiology - 7 • Journal of Hospital Infection - 5 • Journal of Infection - 20 • Journal of Medical Microbiology - 1 • Journal of Virology Current Issue - 11 • Microbiology and Molecular Biology Reviews: Current Issue - 1
• Morbidity and Mortality Weekly Report (MMWR) - 6 • New England Journal of Medicine - Current Issue - 5 • Scandinavian Journal of Infectious Diseases: Table of Contents - 18 • Sexually Transmitted Infection Online First - 1 NIS Affiliation • PubMed: NIS affiliation - 2 Infection-related guidance British Medical Association Reaffirming the importance of human rights in global medicine and healthcare 06 Apr 2022 The BMA's report on human rights covers responsibilities and guidance for doctors working in a radically changed landscape [back to top] British Society for Antimicrobial Chemotherapy Superbug Stories: How a broken leg took 12 years to heal after a resistant infection took hold 05 Apr 2022 Antimicrobial Resistance (AMR) is one of the world’s leading causes of illness and death, causing misery to millions every year. As part of a new series, we are featuring stories of patients who have been affected by AMR, as told to Antibiotic Research UK. In this story, Annabelle explains how a superbug infection took hold following a horse-riding accident. [back to top] European Centre for Disease Prevention and Control Testing for tuberculosis infection and screening for tuberculosis disease among refugees arriving in European countries from Ukraine 07 Apr 2022 This document provides an overview of public health guidance on testing for TB infection, TB preventive treatment and screening for TB disease, in the context of the mass influx of people arriving in European countries from Ukraine. [back to top] Infection-related journals American Journal of Infection Control Health Care-Associated Infections Studies Project: An American Journal of Infection Control and National Healthcare Safety Network Data Quality Collaboration Case Study – Chapter 9 Surgical Site Infection Event (SSI) Case Study 10 Apr 2022 This case study is part of a series centered on the Centers for Disease Control and Prevention/National Healthcare Safety Network (NHSN) healthcare-associated infection
(HAI) surveillance definitions. This specific case study focuses on the application of common surveillance concepts included in the Patient Safety Component, Chapter 9 - Surgical Site Infection Event (SSI) [back to top] Clinical Infectious Diseases - Advance Access Antiretroviral initiation at ≥800 CD4+ cells/ mm 3 associated with lower HIV reservoir size 09 Apr 2022 Spontaneous Clearance Of Vertically Acquired Hepatitis C Infection: Implications For Testing And Treatment 09 Apr 2022 Corrigendum to: Guidance for Systematic Integration of Undernutrition in Attributing Cause of Death in Children 09 Apr 2022 Reply to Author 07 Apr 2022 High SARS-CoV-2 household transmission rates detected by dense saliva sampling 06 Apr 2022 Immune response to LinB13, a Lutzomyia intermedia salivary protein correlates with disease severity in tegumentary leishmaniasis 06 Apr 2022 Bacteremia with Anaerobic Bacteria and Association with Colorectal Cancer: A Population-based Cohort Study 05 Apr 2022 Bacterial STI Incidence among Southern MSM Living with HIV in the Treatment as Prevention Era, 2014-2019 05 Apr 2022 SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study 05 Apr 2022 Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Non-Responding Patient 05 Apr 2022 Pharmacokinetics and Safety of Bedaquiline in HIV-Positive and Negative Older Children and Adolescents with Rifampicin-Resistant Tuberculosis 04 Apr 2022 [back to top] Clinical Infectious Diseases - Current Issue Congenital Human Cytomegalovirus Infection Is Associated With Decreased Transplacental IgG Transfer Efficiency Due to Maternal Hypergammaglobulinemia 10 Apr 2022 Eleanor C Semmes, Shuk Hang Li, Jillian H Hurst, Zidanyue Yang, Donna Niedzwiecki ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1131–1140, https://doi.org/10.1093/cid/ciab627 We evaluated transplacental IgG transfer in a case-
control cohort of mother-infant pairs with and without congenital human cytomegalovirus (cCMV) infection Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020 10 Apr 2022 Patrick Sean Sullivan, Aaron J Siegler, Kayoko Shioda, Eric W Hall, Heather Bradley ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1141–1150, https://doi.org/10.1093/cid/ciab626 One in 8 US adults had been infected with severe acute respiratory syndrome coronavirus 2 by late October 2020; however, few had been accounted for in public health reporting Mother to Infant Transmission of Hepatitis B Virus in the Face of Neonatal Immunization Is Not Necessarily Primary Vaccine Failure 10 Apr 2022 Samreen Ijaz, Jade Derrick, Justin Shute, Georgina Ireland, Iain Hayden ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1151–1157, https://doi.org/10.1093/cid/ciab622 Analysis of virological markers from the neonate and early infancy indicates there are multiple mechanisms associated with HBV transmission from mother to infant Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada 10 Apr 2022 Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1158–1165, https://doi.org/10.1093/cid/ciab616 Vaccine effectiveness estimated by test-negative design in British Columbia, Canada, shows one dose of mRNA vaccine reduced the risk of SARS- CoV-2 infection in adults ≥70-years-old by about Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area 10 Apr 2022 Andreas Wångdahl, Klara Sondén, Katja Wyss, Christine Stenström, David Björklund ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1199–1207, https://doi.org/10.1093/cid/ciab610 The risk of relapse was lower in P. ovale compared to P. vivax. Primaquine treatment significantly reduced the risk of P. vivax relapse, whereas for P An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status 10 Apr 2022 Sheila F Lumley, Gillian Rodger, Bede Constantinides, Nicholas Sanderson, Kevin K Chau ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1208–1219, https://doi.org/10.1093/cid/ciab608 Natural infection resulting in detectable anti-spike antibodies and two vaccine doses both provided ≥85% protection against symptomatic and asymptomatic SARS-CoV-2 infection in healthcare Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2 10 Apr 2022 Louis Grandjean, Anja Saso, Arturo Torres Ortiz, Tanya Lam, James Hatcher ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1220–1229, https://doi.org/10.1093/cid/ciab607 We demonstrate persistence of spike protein and decay of nucleoprotein antibody in serial samples from 349 patients up to 200 days after severe acute respiratory syndrome coronavirus 2 infection and
Anogenital Human Papillomavirus (HPV) Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial 10 Apr 2022 Joseph E Tota, Anna R Giuliano, Stephen E Goldstone, Brady Dubin, Alfred Saah ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1247–1256, https://doi.org/10.1093/cid/ciab603 Among sexually active men in a global vaccine trial, DNA prevalence and seroprevalence for 9-valent human papillomavirus vaccine types was higher in men who have sex with men (vs heterosexual men) but The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV) 10 Apr 2022 Bezawit A Woldemeskel, Andrew H Karaba, Caroline C Garliss, Evan J Beck, Kristy H Wang ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1268–1270, https://doi.org/10.1093/cid/ciab648 Abstract View article Supplementary data Coronavirus Disease 2019–Associated Mucormycosis: Risk Factors and Mechanisms of Disease 10 Apr 2022 Shivakumar Narayanan, Joel V Chua, John W Baddley Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1279–1283, https://doi.org/10.1093/cid/ciab726 The spike in cases of coronavirus disease 2019–associated mucormycosis reported from India during the pandemic surge in early 2021 may be due to an unfortunate alignment of multiple risk factors, chiefly dysglycemia and steroid Undetected and Relatively Sustained Severe Acute Respiratory Syndrome Coronavirus 2 Circulation Worldwide During 2019 10 Apr 2022 Stefano Petti Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1313– 1314, https://doi.org/10.1093/cid/ciab727 Extract View article Working HAND in HAND: Central Nervous System Complications in People with Human Immunodeficiency Virus 10 Apr 2022 Leah H Rubin, Beau M Ances Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Page 1314, https://doi.org/10.1093/cid/ciab723 Extract View article Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) 10 Apr 2022 Chloé Dimeglio, Fabrice Herin, Isabelle Da-Silva, Isabelle Jougla, Claire Pradere ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1315–1316, https://doi.org/10.1093/cid/ciab705 Extract View article Rifampin for Staphylococcal Prosthetic Joint Infection: Do We Still Need a Randomized Controlled Trial? 10 Apr 2022 Henk Scheper, Mark G J De Boer Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1316–1318, https://doi.org/10.1093/cid/ciab704 Extract View article Reply to Scheper and De Boer 10 Apr 2022 Marjan Wouthuyzen-Bakker, Alex Soriano Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Page 1318, https://doi.org/10.1093/cid/ciab706 Extract View article Letter to editor regarding “Clinical Presentation and Outcomes of Pregnant Women With Coronavirus Disease 2019: A Systematic Review and Meta-analysis” 10 Apr 2022
Jianghui Cai, Yonghong Lin, Meng-Jun Wu Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Page 1319, https://doi.org/10.1093/cid/ciab690 Extract View article Reply to Wu, et al 10 Apr 2022 Reem Matar, M Hassan Murad, Layan Alrahmani Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1319–1320, https://doi.org/10.1093/cid/ciab694 Extract View article Correction to: Dose, Timing, and Spectrum of Prenatal Antibiotic Exposure and Risk of Childhood Asthma 10 Apr 2022 Kedir N Turi, Tebeb Gebretsadik, Tan Ding, Andrew Abreo, Cosby Stone ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Page 1321, https://doi.org/10.1093/cid/ciac148 Extract View article Erratum to: Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China 10 Apr 2022 Yubo Wang, Yong He, Jin Tong, Yalan Qin, Ting Xie ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Page 1322, https://doi.org/10.1093/cid/ciab530 Extract View article Longitudinal Assessment of Coronavirus Disease 2019 Vaccine Acceptance and Uptake Among Frontline Medical Workers in Los Angeles, California 10 Apr 2022 Megan Halbrook, Adva Gadoth, Rachel Martin-Blais, Ashley N Gray, Saman Kashani ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1166–1173, https://doi.org/10.1093/cid/ciab614 Trust in coronavirus disease 2019 (COVID-19) vaccines increased markedly over the fall of 2020, primarily owing to increased vaccine communications, and reduced barriers to vaccination through US Hospitalizations and 60-Day Readmission Rates Associated With Herpes Simplex Virus Encephalitis: Analysis of All Cause Readmissions and Encephalopathy Associated Readmissions 10 Apr 2022 Michael A Hansen, Rodrigo Hasbun Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1174–1182, https://doi.org/10.1093/cid/ciab613 Readmissions occurred in approximately 1 of every 4 HSE cases that survived and were often associated with an encephalopathic diagnosis at readmission (12%–20%) Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010–2020 10 Apr 2022 Kevin Outterson, Ebiowei S F Orubu, John Rex, Christine Årdal, Muhammad H Zaman Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1183–1190, https://doi.org/10.1093/cid/ciab612 Antibacterials approved since 2010 are not being commercially launched promptly in many high-income countries, even after regulatory approval Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study 10 Apr 2022 Jessica Seeßle, Tim Waterboer, Theresa Hippchen, Julia Simon, Marietta Kirchner ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1191–1198, https://doi.org/10.1093/cid/ciab611 Neurocognitive long-COVID symptoms can persist at least for 1 year after acute COVID-19 and reduce life quality significantly
Prevalence of Oral Human Papillomavirus Infection: Impact of Sex, Race/Ethnicity, and Vaccination Status 10 Apr 2022 Abbey B Berenson, Jacqueline M Hirth, Mihyun Chang Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1230–1236, https://doi.org/10.1093/cid/ciab605 Oral human papillomavirus prevalence is higher among males than females, vaccinated and unvaccinated, possibly because fewer males get vaccinated before initiating oral sex Cytomegalovirus Viremia and Clinical Outcomes in Kenyan Children Diagnosed With Human Immunodeficiency Virus (HIV) in Hospital 10 Apr 2022 Dalton Wamalwa, Irene Njuguna, Elizabeth Maleche-Obimbo, Emily Begnel, Daisy J Chebet ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1237–1246, https://doi.org/10.1093/cid/ciab604 In Kenyan children ≤ 12 years old diagnosed with human immunodeficiency virus (HIV) in hospital, cytomegalovirus (CMV) viremia at ≥1000 IU/mL was found in 32% of children and associated with Midline Destructive Lesions in Previously Healthy Adult 10 Apr 2022 Elisabeth Gómez-Moyano, Silvestre Martínez García, Maria Ayala-Blanca, Francisco Jimenez Oñate, Leandro Martínez Pilar Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1257–1259, https://doi.org/10.1093/cid/ciz559 Extract View article Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data 10 Apr 2022 Catharine I Paules, Shannon K Gallagher, Rekha R Rapaka, Richard T Davey, Sarah B Doernberg ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1260– 1264, https://doi.org/10.1093/cid/ciab695 Abstract View article Supplementary data COVID-19 Outbreak Associated With a Fitness Center—Minnesota, September–November 2020 10 Apr 2022 Tara Suhs, Daniel Gerlach, Jacob Garfin, Alexandra Lorentz, Melanie Firestone ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1265–1267, https://doi.org/10.1093/cid/ciab653 Abstract View article Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell–Depleted Patients 10 Apr 2022 Arvind Gharbharan, Corine H GeurtsvanKessel, Carlijn C E Jordans, Marc Blaauw, Marjolein van der Klift ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1271– 1274, https://doi.org/10.1093/cid/ciab647 Abstract View article Supplementary data Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination 10 Apr 2022 Crystal M North, Amy Barczak, Robert H Goldstein, Brian C Healy, Dianne M Finkelstein ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1275–1278, https://doi.org/10.1093/cid/ciab643 Abstract View article Supplementary data Envisioning Future Urinary Tract Infection Diagnostics 10 Apr 2022 Robin Patel, Christopher R Polage, Jennifer Dien Bard, Larissa May, Francesca M Lee ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1284–1292, https://doi.org/10.1093/cid/ciab749 Urinary tract infections are among the most common bacterial infections in the United States and are a major driver of antibiotic use, both appropriate and inappropriate, across healthcare
Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies 10 Apr 2022 John Jacob, Argon Steel, Zhain Lin, Fiona Berger, Katrin Zöeller ... Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1293–1302, https://doi.org/10.1093/cid/ciab730 Historically, there have been concerns in using benzimidazole anthelmintics for neuroangiostrongyliasis management Cefiderocol: A New Cephalosporin Stratagem Against Multidrug- Resistant Gram-Negative Bacteria 10 Apr 2022 Sharon Ong’uti, Mary Czech, Elizabeth Robilotti, Marisa Holubar Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages 1303–1312, https://doi.org/10.1093/cid/ciab757 Cefiderocol, a siderophore cephalosporin, demonstrates in vitro activity against multidrug- resistant gram-negative bacteria and is approved for complicated urinary tract infections and nosocomial pneumonia caused by Erratum to: Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa 10 Apr 2022 Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, South Africa Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Page 1321, https://doi.org/10.1093/cid/ciab803 Extract View article 1 April 2022—In the Literature 10 Apr 2022 Clinical Infectious Diseases, Volume 74, Issue 7, 1 April 2022, Pages i–ii, https://doi.org/10.1093/cid/ciac093 Extract View article [back to top] Clinical Microbiology and Infection Antilogic, a new supervised machine learning software for the automatic interpretation of antibiotic susceptibility testing in clinical microbiology: proof-of-concept on three frequently isolated bacterial species 10 Apr 2022 Publication date: Available online 8 April 2022Source: Clinical Microbiology and InfectionAuthor(s): Andriamiharimamy Rajaonison, Stéphanie Le Page, Thomas Maurin, Hervé Chaudet, Didier Raoult, Sophie Alexandra Baron, Jean-Marc Rolain Learning from and optimising divergent pandemic responses 08 Apr 2022 Publication date: Available online 7 April 2022Source: Clinical Microbiology and InfectionAuthor(s): Julian W. Tang, Kin On Kwok ‘Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil' – Author’s reply 07 Apr 2022 Publication date: Available online 6 April 2022Source: Clinical Microbiology and InfectionAuthor(s): Otavio T. Ranzani, Fernando A. Bozza, all co-authors 'Treatment of Coxiella burnetii endocarditis with hydroxychloroquine' – Author’s reply 07 Apr 2022 Publication date: Available online 6 April 2022Source: Clinical Microbiology and InfectionAuthor(s): J.P. Stahl, E. Varon, J.P. Bru
Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy 05 Apr 2022 Publication date: Available online 4 April 2022Source: Clinical Microbiology and InfectionAuthor(s): Laura Butragueño-Laiseca, Nicolás Marco-Ariño, Iñaki F. Troconiz, Santiago Grau, Nuria Campillo, Xandra García, Belén Padilla, Sarah Nicole Fernández, María Slöcker, María José Santiago [back to top] Emerging Infectious Diseases Journal - ahead of print Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022 08 Apr 2022 H. Gu et al. Evidence of Prolonged Crimean-Congo Hemorrhagic Fever Virus Endemicity by Retrospective Serosurvey, Eastern Spain 07 Apr 2022 L. Carrera-Faja et al. Emerging Novel Reassortant Influenza A(H5N6) Viruses in Poultry and Humans, China, 2021 07 Apr 2022 W. Jiang et al. Novel Hendra Virus Variant Circulating in Black Flying Foxes and Grey- Headed Flying Foxes, Australia 07 Apr 2022 A. J. Peel et al. Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain 07 Apr 2022 J. Del Águila-Mejía et al. Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986–2018 06 Apr 2022 A. Mir-Cros et al. Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic Risk 06 Apr 2022 J. Cheung et al. Highly Pathogenic Avian Influenza A(H5N8) Clade 2.3.4.4b Viruses in Satellite-Tracked Wild Ducks, Ningxia, China, 2020 06 Apr 2022 X. Lv et al. SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan 06 Apr 2022 W. Moser et al. Breast Milk as Route of Tick-Borne Encephalitis Virus Transmission from Mother to Infant 06 Apr 2022 J. Kerlik et al. Lack of Evidence for Crimean–Congo Hemorrhagic Fever Virus in Ticks Collected from Animals, Corsica, France
06 Apr 2022 V. Cicculli et al. Angiostrongylus cantonensis in a Red Ruffed Lemur at a Zoo, Louisiana, USA 06 Apr 2022 J. Rizor et al. Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021 04 Apr 2022 H. Vauhkonen et al. [back to top] European Journal of Clinical Microbiology & Infectious Diseases Rapid LC–MS/MS detection of different carbapenemase types in carbapenemase-producing Enterobacterales 09 Apr 2022 Abstract Klebsiella pneumoniae carbapenemase (KPC)-2, metallo-beta-lactamases (MBL), and oxacillinase (OXA)-48-like carbapenemases are considered the most important carbapenemases. In vitro studies have demonstrated that the carbapenemase activity of KPC-2 and MBL can be inhibited by 3-aminophenylboronic acid and ethylenediaminetetraacetic acid (EDTA), respectively Non-structural protein 1 (NS1) variants from dengue virus clinical samples revealed mutations that influence NS1 production and secretion 09 Apr 2022 Abstract Dengue diagnosis primarily relies on NS1 ELISA and serological (IgG/IgM) tests. There are reports of low and variable sensitivity of the widely used NS1 ELISA tests. Poor sensitivity has been attributed to patient’s infection status, prevalent serotypes, and the geographical origin of the samples Antimicrobial susceptibility testing is crucial when treating Finegoldia magna infections 07 Apr 2022 Abstract Finegoldia magna is an anaerobic gram-positive bacterium that can cause invasive human infections. Recently, a 52-year-old patient suffering from a periprosthetic joint infection (PJI) due to F. magna was treated with cefepime on hemodialysis; however, treatment failed due to relapse caused by antibiotic-resistant strains. Reports on the antimicrobial susceptibility of F [back to top] Eurosurveillance latest updates HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019 07 Apr 2022 Introduction Despite increased use of pre-exposure prophylaxis (PrEP) in Germany, HIV infection rates are not declining and little is known about how this prevention method affects the prevalence of sexually transmitted infections (STI) among men who have sex with men (MSM) HIV-1-infection in a man who has sex with men despite self-reported excellent adherence to pre-exposure prophylaxis, the Netherlands,
August 2021: be alert to emtricitabine/tenofovir-resistant strain transmission 07 Apr 2022 In August 2021, a man who has sex with men was diagnosed with HIV-1 infection despite using event-driven pre-exposure prophylaxis for over 2 years with self-reported excellent adherence. Sequencing identified resistance-associated mutations (RAM) M184V and K65R, conferring resistance to emtricitabine and tenofovir, and RAM V108I and E138A. Background RAM prevalence was two of 164 (1 Job vacancy at Eurosurveillance / ECDC 07 Apr 2022 Prevalence of sexually transmitted infections with Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis: findings from the National Survey of Sexual Lifestyles, Attitudes and Health, Slovenia, 2016 to 2017 07 Apr 2022 Background To inform prevention and control of sexually transmitted infections (STIs), we need reliable prevalence estimates. Aim One objective of the Slovenian National Survey of Sexual Lifestyles, Attitudes and Health was to estimate the prevalence of STIs with Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross- sectional study, Germany, 2018 and 2019 07 Apr 2022 Introduction Users of pre-exposure prophylaxis (PrEP) require periodic testing for HIV, sexually transmitted infections (STI) and renal function. Before PrEP was made free of charge through statutory health insurance in late 2019, PrEP users in Germany had to pay for testing themselves [back to top] Hepatology Letter to the editor: HBeAg expression suppressing/abolishing mutation elevated HBV DNA level in HBeAg‐negative patients with chronic HBV infection 05 Apr 2022 Hepatology, Accepted Article. [back to top] Infection Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests 09 Apr 2022 Abstract Purpose The objective of this study was to develop a scalable approach for direct comparison of the analytical sensitivities of commercially available SARS-CoV-2 antigen point-of-care tests (AgPOCTs) to rapidly identify poor-performing products Myelitis with flaccid paralysis due to Japanese encephalitis: case report and review of the literature 09 Apr 2022 Abstract Background Japanese encephalitis is an arthropod-borne zoonotic flavivirus infection endemic to tropical and subtropical Asia. A minority of infections leads to a symptomatic course, but affected patients often develop life-threatening encephalitis with severe sequelae
Correspondence to: hemophagocytic lymphohistiocytosis after SARS- CoV-2 vaccination 07 Apr 2022 Durability of anti-spike antibodies after vaccination with mRNA SARS- CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed? 07 Apr 2022 Abstract Purpose The long-term effectiveness of BNT162b2/Pfizer vaccine remains undetermined. This observational prospective study was designed to verify durability of antibodies against the viral receptor-binding domain (RBD) spike (S)-protein (RBD S-Protein IgG) after the second-dose administration of the vaccine among Health Care Workers (HCWs) Evaluating current practice and knowledge about antibiotic stewardship principles in paediatric tertiary hospitals to identify target areas for future teaching activities 02 Apr 2022 Abstract Purpose Antibiotic exposure among hospitalized children is very high. With inappropriate antimicrobial use resulting in increased rates of antimicrobial resistance, the implementation of antibiotic stewardship programs is critically needed [back to top] Infection Control & Hospital Epidemiology - FirstView Article Quantitative fit-test concordance of a pair of similar-fit 3M Aura respirator models, 3M 9320A+ and 3M 1870+: A randomized crossover study 07 Apr 2022 Published online by Cambridge University Press: A mixed-methods evaluation on the efficacy and perceptions of needleless connector disinfectants 07 Apr 2022 Published online by Cambridge University Press: Protein detection by fluorescence of manually cleaned high-speed dental handpieces 07 Apr 2022 Published online by Cambridge University Press: Decline in oral antimicrobial prescription in the outpatient setting after nationwide implementation of financial incentives and provider education: An interrupted time-series analysis 06 Apr 2022 Published online by Cambridge University Press: Effect of influenza vaccination among healthcare workers on hospital- acquired influenza in short-stay hospitalized patients: A multicenter pilot study in France 06 Apr 2022 Published online by Cambridge University Press: Tuberculosis attributed to transmission within healthcare facilities, Botswana—The Kopanyo Study 06 Apr 2022 Published online by Cambridge University Press:
Factors associated with coronavirus disease 2019 (COVID-19) among Thai healthcare personnel with high-risk exposures: The important roles of double masking and physical distancing while eating 18 Mar 2022 Published online by Cambridge University Press: [back to top] International Journal of Infectious Diseases Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: Example from an Israeli Healthcare worker cohort 10 Apr 2022 Publication date: Available online 9 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Kamal Abu Jabal, Michael Edelstein Characteristics of human leptospirosis in three different geographical and climatic zones of Vietnam: A hospital-based study 10 Apr 2022 Publication date: Available online 10 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Le Thi Phuong Mai, Luu Phuong Dung, Tran Ngoc Phuong Mai, Nguyen Thi My Hanh, Phan Dang Than, Tran Van Dinh, Nguyen Tu Quyet, Hoang Hai, Do Bich Ngoc, Pham Thanh Hai, Luong Minh Hoa, Nguyen Thi Thu, Tran Nhu Duong, Dang Duc Anh Posaconazole or Isavuconazole as sole or predominant anti-fungal therapy for COVID-19 associated Mucormycosis. A retrospective observational case series 10 Apr 2022 Publication date: Available online 9 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Rajeev Soman, Sourabh Chakraborty, Geethu Joe Response to Abdelrahman M et al commentary on “Parasites Protect from Severe COVID-19. Myth or Reality?” 10 Apr 2022 Publication date: Available online 9 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Dawit Wolday, Tobias F. Rinke de Wit Surgical Treatment of Nontuberculous Mycobacterial Pulmonary Disease, and a Combination of Nontuberculous Mycobacterium Pulmonary Disease and Pulmonary Tuberculosis 08 Apr 2022 Publication date: Available online 8 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Dmitrii Borisivich Giller, Galina Vladimirovna Shcherbakova, Andrey Nikolaevich Gerasimov, Sergey Viktorovich Smerdin, Ivan Ivanivich Martel, Oleg Schamilevich Kesaev, Vadim Valerievich Koroev, Lyudmila Petrovna Severova Superinfection is associated with short-term outcome and mortality in viral respiratory tract infections during the fall-winter seasons 2016- 2018 in the Greater Paris area: the SUPERFLUOUS study 08 Apr 2022 Publication date: Available online 8 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Benjamin Davido, Benoit Lemarie, Elyanne Gault, Marion Pepin, Karim Jaffal, Sebastien Beaune, Lotfi Dahmane, Jennifer Dumoulin, Segolene Greffe, Djillali Annane, Pierre De Truchis Effect of a Two-Dose vs Three-Dose Vaccine Strategy in Residential Colleges Using an Empirical Proximity Network 08 Apr 2022 Publication date: Available online 8 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Hali L. Hambridge, Rebecca Kahn, Jukka-Pekka Onnela
Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India 07 Apr 2022 Publication date: Available online 28 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Arup Ghosh, Safal Walia, Roma Rattan, Amol Kanampalliwar, Atimukta Jha, Shifu Aggarwal, Sana Fatma, Niyati Das, Nirupama Chayani, Punit Prasad, Sunil K. Raghav, Ajay Parida Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste 07 Apr 2022 Publication date: Available online 28 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Paul Arkell, Celia Gusmao, Sarah L. Sheridan, Maria Y. Tanesi, Nelia Gomes, Tessa Oakley, Johanna Wapling, Lucsendar Alves, Stacey Kopf, Nevio Sarmento, Ismael Da Costa Barreto, Salvador Amaral, Anthony D.K A 10-year Review of TB Notifications and Mortality Trends Using a Joint Point Analysis in Zambia - a High TB burden country: Invited article – IJID World TB Day Series 2022 07 Apr 2022 Publication date: Available online 29 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Patrick Lungu, Clara Kasapo, Reford Mihova, Rhehab Chimzizi, Lyapa Sikazwe, Isaac Banda, Luchenga Adam Mucheleng'anga, Pascalina Chanda-Kapata, Nathan Kapata, Alimuddin Zumla, Peter Mwaba Third of patients have gustatory dysfunction 9 months after SARS-CoV- 2 infection: the ANOSVID study 07 Apr 2022 Publication date: Available online 30 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Timothée Klopfenstein, Can Tipirdamaz, Vincent Gendrin, Molka Osman, Julien Mercier, Elodie Bouvier, Kevin Bouiller, Quentin Lepiller, Lynda Toko, Alix Pierron, Pierre-Yves Royer, Pauline Garnier, N'dri-Juliette Kadiane-Oussou, Catherine Chirouze, Souheil Zayet Clinical Characteristics of HIV-associated Talaromyces marneffei Infection of Intestine in Southern China 07 Apr 2022 Publication date: Available online 6 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Zhiman Xie, Jingzhen Lai, Renping Peng, Minhong Mou, Hao Liang, Chuanyi Ning Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality 07 Apr 2022 Publication date: Available online 6 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Kevin B. Laupland, David L. Paterson, Adam G. Stewart, Felicity Edwards, Patrick N.A. Harris Extrapulmonary pneumocystosis in an antiretroviral therapy-naïve, HIV- positive patient 07 Apr 2022 Publication date: Available online 6 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Makoto Hasegawa, Yuji Ito, Yasuhiro Osugi, Masahiro Hashimoto, Nanako Hashimoto, Kunio Yano Contribution of CD4+ T cell mediated inflammation to diarrhoea in patients with COVID-19 07 Apr 2022 Publication date: Available online 6 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Xiaobing Wang, Jia Wei, Ruiping Zhu, Liping Chen, Feng Ding, Rui Zhou, Liuqing Ge, Jun Xiao, Qiu Zhao
Application of noninvasive positive pressure ventilation to respiratory complications of severe tetanus: a case report 07 Apr 2022 Publication date: Available online 6 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Keita Imanishi, Kazuhiro Yasuo Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns 07 Apr 2022 Publication date: Available online 6 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Lee Lee Ho, Santosh Gurung, Imran Mirza, Hemanthi Dassanayake Nicolas, Claudia Steulet, Ashley L Burman, M. Carolina Danovaro-Holliday, Samir V. Sodha, Katrina Kretsinger Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting 07 Apr 2022 Publication date: Available online 30 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Sabrina Jegerlehner, Franziska Suter-Riniker, Philipp Jent, Pascal Bittel, Michael Nagler Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19 07 Apr 2022 Publication date: Available online 28 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Ian Jackson, Hadi Jaradeh, Sarah Aurit, Ali Aldamen, Shraddha Narechania, Christopher Destache, Manasa Velagapudi Armed conflict and human displacement may lead to an increase in the burden of tuberculosis in Europe 07 Apr 2022 Publication date: Available online 29 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Victor Dahl, Simon Tiberi, Delia Goletti, Christian Wejse Antimicrobial Resistance Through the Lens of One Health in Ethiopia: A Review of the Literature Among Humans, Animals, and the Environment 07 Apr 2022 Publication date: Available online 28 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Ayako Wendy Fujita, Kaitlyn Werner, Jesse T. Jacob, Rea Tschopp, Gezahegne Mamo, Adane Mihret, Alemseged Abdissa, Russell Kempker, Paulina A. Rebolledo Nosocomial outbreak of severe fever with thrombocytopenia syndrome among healthcare workers in a single hospital in Daegu, Korea 07 Apr 2022 Publication date: Available online 28 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Sohyun Bae, Hyun-Ha Chang, Shin-Woo Kim, Yoonjung Kim, EunByeol Wang, Chi Kyeong Kim, Eunji Choi, Bohyun Lim, Sookkyung Park, Hwajin Chae, Hyeyoung Jeon Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020 07 Apr 2022 Publication date: Available online 30 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Steven I. Aronin, Vikas Gupta, Michael W. Dunne, Janet A. Watts, Kalvin C. Yu Varicella zoster meningitis following COVID-19 vaccination: a report of two cases 07 Apr 2022
Publication date: Available online 30 March 2022Source: International Journal of Infectious DiseasesAuthor(s): Marturod Buranasakda, Praew Kotruchin, Kittisap Phanthachai, Piroon Mootsikapun, Ploenchan Chetchotisakd Variations in the appearance of posterior pharyngeal wall follicles in individuals with viral upper respiratory infections according to the virus and the stage of infection: A case series 07 Apr 2022 Publication date: Available online 1 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Hidenori Takahashi The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections 07 Apr 2022 Publication date: Available online 6 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Vanessa di Lego, Miguel Sánchez-Romero, Alexia Prskawetz Varicella Zoster Virus (VZV) Meningitis in an Immunocompetent Adult following BNT162b2 mRNA COVID-19 Vaccination: A Case Report 07 Apr 2022 Publication date: Available online 6 April 2022Source: International Journal of Infectious DiseasesAuthor(s): R Medhat, R El Lababidi, M Abdelsalam, A Nusair Lassa Virus Infection: a Summary for Clinicians 07 Apr 2022 Publication date: Available online 6 April 2022Source: International Journal of Infectious DiseasesAuthor(s): Vanessa Raabe, Aneesh K Mehta, Jared D. Evans [back to top] Journal of Clinical Microbiology Multicenter Evaluation of the BioFire Respiratory Panel 2.1 (RP2.1) for Detection of SARS-CoV-2 in Nasopharyngeal Swab Samples 07 Apr 2022 Journal of Clinical Microbiology, Ahead of Print. Accuracy of Pneumocystis jirovecii Plasma Cell-Free DNA PCR for Noninvasive Diagnosis of Pneumocystis Pneumonia 07 Apr 2022 Journal of Clinical Microbiology, Ahead of Print. The Ins and Outs of Susceptibility Testing for New β-Lactam/β- Lactamase Inhibitor Combinations for Gram-Negative Organisms 07 Apr 2022 Journal of Clinical Microbiology, Ahead of Print. Development of a Bead-Based Multiplex Assay for Use in Multianalyte Screening and Surveillance of HIV, Viral Hepatitis, Syphilis, and Herpes 07 Apr 2022 Journal of Clinical Microbiology, Ahead of Print. Saving Time in Blood Culture Diagnostics: a Prospective Evaluation of the Qvella FAST-PBC Prep Application on the Fast System 07 Apr 2022 Journal of Clinical Microbiology, Ahead of Print. Commentary: Can Automated Blood Culture Systems Be Both New and Improved? 04 Apr 2022 Journal of Clinical Microbiology, Ahead of Print.
SARS-CoV-2 Testing in the Community: Testing Positive Samples with the TaqMan SARS-CoV-2 Mutation Panel To Find Variants in Real Time 04 Apr 2022 Journal of Clinical Microbiology, Ahead of Print. [back to top] Journal of Hospital Infection Infection control strategies for patients and accompanying persons during the COVID-19 pandemic in German hospitals – Results from a cross-sectional study in March-April 2021 09 Apr 2022 Patients are at risk of nosocomial COVID-19 infection. The role of accompanying persons/visitors as potential infection donors is not yet well-known, but the risk will be influenced by prevention measures recommended by infection control practitioners. Hinged surgical instruments: efficacy of double manual cleaning versus automated cleaning on biofilm removal 08 Apr 2022 The efficacy of double manual cleaning (DMC) with enzymatic detergent followed by alkaline detergent on biofilm removal on hinged surgical instruments was compared to automated cleaning. Biofilm covered haemostatic forceps were divided into four groups: positive control (soaked in sterile water); DMC; DMC plus extra brushing of the inner hinge; and automated cleaning Low efficacy of three non-alcohol-based hand disinfectants utilizing silver polymer, lactic acid and benzalkonium chloride on inactivation of bacteria in healthcare workers’ fingertips 06 Apr 2022 Recently, new non-alcohol-based hand disinfection formulae have come to the market. Although they have passed the EN1500 test, data on their clinical efficacy compared with alcohol-based hand rubs is scarce, covering mainly benzalconium chloride (BAC). Change from Transrectal to Transperineal Ultrasound-Guided Prostate Biopsy under local anaesthetic eliminates sepsis as a complication. 04 Apr 2022 Transrectal ultrasound-guided (TRUS) biopsy of the prostate is associated with an increased risk of post-procedural sepsis with associated morbidity, mortality, readmission to hospital and increased healthcare costs Catheter salvage strategies in children with central venous catheter related or associated bloodstream infections: a systematic review and meta-analysis 04 Apr 2022 Optimal management of Central Venous Catheter related, or associated, bloodstream infections (CRBSI or CLABSI) in children is not established. [back to top] Journal of Infection Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England” 10 Apr 2022 We read with interest the publication by Chappell et al reporting a very low risk of severe COVID in immunosuppressed children in England. 1
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial. 08 Apr 2022 Many countries elected to deploy 3rd dose booster vaccines against COVID-19 towards the end of 2021 as a result of waning immunity and emergence of variants with varying degrees of immune escape, (1). Results previously published from the COV-BOOST study demonstrated that most COVID-19 vaccines delivered as a 3rd dose booster provided a significant boost to both humoral and cellular immunity at Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network 08 Apr 2022 Antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can usually be detected following infection, whether symptomatic or asymptomatic. The seroprevalence of SARS-CoV-2 antibodies in the population serves as a measure of past exposure and population immunity.1 Community serological surveys allow monitoring of changes over time, and comparisons between sociodemographic groups. How China responds to Omicron 08 Apr 2022 Recently, a letter in your journal predicted that the SARS-CoV-2 Omicron strain will thereby replace the Delta variant as the dominant strain (1). This prediction has become ever more salient due to the new wave of COVID-19 outbreaks that has occurred in China. This round of epidemic is mainly caused by the Omicron subtype BA.2 SARS-CoV2 Antibody Response After a Third Dose of Heterologous ChAdOx1 nCoV-19 and Moderna Vaccine in Chronic Dialysis Patients 07 Apr 2022 The battle against coronavirus disease 2019 (COVID-19) remains the biggest challenge in controlling the spread of the disease globally. In this Journal, the report by Li and colleagues highlighted the danger to renal dialysis patients in the COVID-19 pandemic (1) High vaccination coverage slows down genetic diversity of SARS-CoV- 2 07 Apr 2022 A third dose of COVID-19 vaccine has been proved to be necessary to boost antibody level after vaccination for six months [1]. However, the emerging variants of concern (VOC) such as Delta and Omicron tend to weaken the protection of current vaccines [2]. With the observed waning effectiveness of booster shots [3], whether to get additional doses of vaccine in the future remains an open question Outcome of very high-risk patients treated by Sotrovimab for mild-to- moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S CoCoPrev study) 07 Apr 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related coronavirus disease 2019 (COVID-19) manifests with symptoms ranging from fully asymptomatic to severe disease. Many risk factors have been identified in the progression of COVID-19 into a severe stage, including old age, male gender, underlying comorbidities, immunodeficiencies, and pregnancy 1 Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021 07 Apr 2022 Dear Editor, Serum C reactive protein predicts humoral response after BNT162b2 booster administration 07 Apr 2022
Although vaccination against coronavirus disease 2019 (COVID-19) is now considered the most efficient measure for preventing severe acute coronavirus disease 2 (SARS-CoV-2) infections and disease-related complications [1], the humoral response to vaccines and its consequent efficacy may be strongly influenced by demographic and clinical variables [2] The impact of COVID-19 on the molecular epidemiology of seasonal viral respiratory infections, Cyprus 07 Apr 2022 As a global health problem, the COVID-19 pandemic continues to surge with more than 428 million cases and over 5.9 million deaths reported as of February 2022.1 The global response aimed at fighting the pandemic, including temporary lockdowns, mask wearing, social distancing, enhanced personal hygiene and reduced travel has had a significant impact on the prevention of new cases and has slowed Inadequate protection against measles and rubella among pregnant women in Greece during the last measles outbreak 06 Apr 2022 Dear Editor, Prognostic value of maximum NEWS-2 scores in addition to ISARIC 4C scores for patients admitted to hospital with COVID-19 06 Apr 2022 Dear Editor Nosocomial septicemia in COVID-19 Nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica Septicemia in a Patient of COVID-19 05 Apr 2022 To the Editor: Prevalence and genetic diversity of Dabieshan tick virus in Shandong Province, China 05 Apr 2022 Dear editor SARS-CoV-2 rapid test versus RT-qPCR on noninvasive respiratory self-samples during a city mass testing campaign. 05 Apr 2022 A few months ago, Baro et al. published in this Journal an interesting study comparing different rapid lateral-flow tests (RLFT) dedicated to the direct diagnosis of SARS-CoV-2 in nasopharyngeal aspirates in a large population of asymptomatic subjects in Catalonia, Spain Acute respiratory infections in children, before and after the COVID-19 pandemic, a sentinel study 04 Apr 2022 Dear editor, Peculiar H3N2 outbreak in São Paulo during summer and emergence of the Omicron variant 04 Apr 2022 Influenza virus is associated with considerable morbidity and mortality worldwide. These epidemics occur annually and can be prevented through prophylactic vaccination and mitigated with interventions such as social control measures and specific antiviral use (1,2) FilmArray Meningitis/Encephalitis (M/E) false-negative for cryptococcal meningitis 04 Apr 2022 Dear Editor, Prolonged viral shedding in severely ill patients infected with SARS- CoV-2 Delta variants: a retrospective cohort study 04 Apr 2022 Non-pharmaceutical interventions (NPIs) and vaccination programs have played crucial roles in mitigating a novel coronavirus disease 2019 (COVID-19) pandemic. The isolation of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected individuals is one of the important and effective NPIs (1) Editorial Board 01 Apr 2022 [back to top] Journal of Medical Microbiology Development of an ELISA to distinguish between foot-and-mouth disease virus infected and vaccinated animals utilising the viral non- structural protein 3ABC 06 Apr 2022 Introduction. Foot-and-mouth disease (FMD) is a highly contagious and economically devastating viral disease of livestock and is endemic in much of Asia, including Pakistan. Vaccination is used to control disease outbreaks and sensitive diagnostic methods which can differentiate infected animals from vaccinated animals (DIVA) are essential for monitoring the effectiveness of disease control [back to top] Journal of Virology Current Issue Two Novel Rhabdoviruses Related to Hypervirulence in a Phytopathogenic Fungus 07 Apr 2022 Journal of Virology, Ahead of Print. The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine 07 Apr 2022 Journal of Virology, Ahead of Print. Region-Specific Hepatitis B Virus Genome Exposure from Nucleocapsid Modulated by Capsid Linker Sequence and Inhibitor: Implications for Uncoating 07 Apr 2022 Journal of Virology, Ahead of Print. Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332 07 Apr 2022 Journal of Virology, Ahead of Print. BK Polyomavirus Requires the Mismatch Repair Pathway for DNA Damage Response Activation 07 Apr 2022 Journal of Virology, Ahead of Print. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog 07 Apr 2022 Journal of Virology, Ahead of Print. Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice 07 Apr 2022 Journal of Virology, Ahead of Print. Evolution and Genetic Diversity of the Retroviral Envelope in Anamniotes
07 Apr 2022 Journal of Virology, Ahead of Print. Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses 06 Apr 2022 Journal of Virology, Ahead of Print. An Unusual Aspartic Acid Cluster in the Reovirus Attachment Fiber σ1 Mediates Stability at Low pH and Preserves Trimeric Organization 05 Apr 2022 Journal of Virology, Ahead of Print. A System Based on Novel Parainfluenza Virus PIV5-L for Efficient Gene Delivery of B-Lymphoma Cells 04 Apr 2022 Journal of Virology, Ahead of Print. [back to top] Microbiology and Molecular Biology Reviews: Current Issue Microbial Biogeochemical Cycling of Nitrogen in Arid Ecosystems 07 Apr 2022 Microbiology and Molecular Biology Reviews, Ahead of Print. [back to top] Morbidity and Mortality Weekly Report (MMWR) EARLY RELEASE: COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022 08 Apr 2022 This report describes COVID-19 vaccination coverage and death rates during a rise in COVID-19-associated deaths in Hong Kong. Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021 07 Apr 2022 This report describes a confirmed case of Monkeypox virus in the U.S. Notes from the Field: Enteropathogenic Escherichia coli Outbreak at a Child Care Center - Oregon, August 2021 07 Apr 2022 This report describes an E. coli outbreak at an Oregon child care center. Erratum: Vol. 71, No. 6 07 Apr 2022 Erratum for MMWR Vo. 71, No. 06 Notes from the Field: SARS-CoV-2 Omicron Variant Infection in 10 Persons Within 90 Days of Previous SARS-CoV-2 Delta Variant Infection - Four States, October 2021-January 2022 07 Apr 2022 This report describes 10 people who were infected with the COVID-19 Omicron variant within 90 days of Delta variant infection. QuickStats: Rate of Deaths Attributed to Unintentional Injury from Fire or Flames,† by Sex and Urban-Rural Status§ - National Vital Statistics System, United States, 2020 07 Apr 2022 This report describes death rates from unintentional injury from fire or flames. [back to top]
New England Journal of Medicine - Current Issue Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers 06 Apr 2022 New England Journal of Medicine, Ahead of Print. Omicron — Decoupling Infection from Severe Disease 06 Apr 2022 New England Journal of Medicine, Volume 386, Issue 14, Page 1361-1362, April 2022. Pulse Oximetry for Monitoring Patients with Covid-19 at Home — A Pragmatic, Randomized Trial 06 Apr 2022 New England Journal of Medicine, Ahead of Print. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection 06 Apr 2022 New England Journal of Medicine, Volume 386, Issue 14, Page 1327-1338, April 2022. Protection by a Fourth Dose of BNT162b2 against Omicron in Israel 05 Apr 2022 New England Journal of Medicine, Ahead of Print. [back to top] Scandinavian Journal of Infectious Diseases: Table of Contents Clinical frailty scale as a predictor of disease severity in patients hospitalised with COVID-19 – an observational cohort study 08 Apr 2022 . PIMS-TS immunophenotype: description and comparison with healthy children, Kawasaki disease and severe viral and bacterial infections 08 Apr 2022 . Risk of severe illness in patients infected with SARS-CoV-2 of Delta variant: a systematic review and meta-analysis 07 Apr 2022 . Iranian patients co-infected with COVID-19 and mucormycosis: the most common predisposing factor, clinical outcomes, laboratory markers and diagnosis, and drug therapies 07 Apr 2022 . Sensitisation and allergic reactions to alpha-1,3-galactose in Podlasie, Poland, an area endemic for tick-borne infections 06 Apr 2022 . Sensitisation of Forest workers to the oligosaccharide galactose alpha- 1, 3-galactose (alpha-gal) is strongly associated with tick bites but not with evidence of tick borne infections 06 Apr 2022 .
You can also read